Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selective Depletion of Naive Cells From the Graft in Children With CID
NCT02737384Phase 2Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2016
- Primary completion
- Oct 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CD45RA-depleted peripheral blood stem cells in combined immunodeficiency (CID), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2016; status: terminated.
02
Drugs
CD45RA-depleted peripheral blood stem cells
03
Conditions
combined immunodeficiency (CID)
Beyond the preview
Go deeper on NCT02737384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737384.